2025-08-28 |
13G
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
3,027,977 |
|
|
|
2025-08-14 |
13G/A
|
JANX / Janux Therapeutics, Inc.
|
|
3,515,986 |
2,920,258 |
|
|
|
2025-08-14 |
13G/A
|
COGT / Cogent Biosciences, Inc.
|
|
8,963,655 |
10,352,449 |
|
|
|
2025-08-12 |
13G
|
URGN / UroGen Pharma Ltd.
|
|
|
2,332,066 |
|
|
|
2025-07-30 |
13G
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
1,128,613 |
|
|
|
2025-05-15 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
3,059,411 |
0 |
|
|
|
2025-05-15 |
13G/A
|
IRON / Disc Medicine, Inc.
|
|
1,497,720 |
1,210,971 |
|
|
|
2025-05-15 |
13G/A
|
COGT / Cogent Biosciences, Inc.
|
|
5,559,924 |
8,963,655 |
|
|
|
2025-04-10 |
13G
|
MRUS / Merus N.V.
|
|
|
3,554,059 |
|
|
|
2025-03-27 |
13G
|
LENZ / LENZ Therapeutics, Inc.
|
|
|
1,419,832 |
|
|
|
2025-02-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
5,503,600 |
7,429,355 |
|
|
|
2025-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
4,331,321 |
0 |
|
|
|
2025-02-14 |
13G/A
|
JANX / Janux Therapeutics, Inc.
|
|
2,608,574 |
3,515,986 |
|
|
|
2025-02-12 |
13G
|
COGT / Cogent Biosciences, Inc.
|
|
|
5,559,924 |
|
|
|
2025-02-03 |
13G
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
4,738,929 |
|
|
|
2024-11-14 |
13G/A
|
NUVL / Nuvalent, Inc.
|
|
3,858,008 |
5,000,000 |
|
|
|
2024-11-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
7,903,600 |
5,503,600 |
|
|
|
2024-11-14 |
13G/A
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
3,425,988 |
2,320,000 |
|
|
|
2024-11-14 |
13G/A
|
ACLX / Arcellx, Inc.
|
|
3,658,624 |
4,800,000 |
|
|
|
2024-11-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
1,927,506 |
2,440,445 |
|
|
|
2024-11-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
3,861,318 |
4,331,321 |
|
|
|
2024-11-14 |
13G/A
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
12,611,335 |
0 |
|
|
|
2024-11-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
3,707,001 |
0 |
|
|
|
2024-11-14 |
13G/A
|
IRON / Disc Medicine, Inc.
|
|
2,385,857 |
1,497,720 |
|
|
|
2024-11-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
5,304,313 |
3,509,253 |
|
|
|
2024-11-14 |
13G/A
|
VOR / Vor Biopharma Inc.
|
|
6,457,293 |
0 |
|
|
|
2024-11-14 |
13G/A
|
YMAB / Y-mAbs Therapeutics, Inc.
|
|
2,198,312 |
4,086,346 |
|
|
|
2024-10-23 |
13G
|
JANX / Janux Therapeutics, Inc.
|
|
|
2,608,574 |
|
|
|
2024-10-04 |
13G
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
3,059,411 |
|
|
|
2024-05-02 |
13G
|
KURA / Kura Oncology, Inc.
|
|
|
3,861,318 |
|
|
|
2024-04-08 |
13G
|
YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
2,198,312 |
|
|
|
2024-02-14 |
13G/A
|
ACLX / Arcellx, Inc.
|
|
2,422,700 |
3,658,624 |
|
|
|
2024-02-14 |
13G/A
|
AMAM / Ambrx Biopharma Inc.
|
|
|
4,502,689 |
|
|
|
2024-02-14 |
13G/A
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
10,098,584 |
12,611,335 |
|
|
|
2024-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
2,317,634 |
3,176,743 |
|
|
|
2024-02-14 |
13G/A
|
IRON / Disc Medicine, Inc.
|
|
1,235,918 |
2,385,857 |
|
|
|
2024-02-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
1,610,665 |
3,707,001 |
|
|
|
2024-02-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
7,803,600 |
7,903,600 |
|
|
|
2024-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
2,310,698 |
5,304,313 |
|
|
|
2024-02-14 |
13G
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
399,658 |
0 |
|
|
|
2024-02-14 |
13G/A
|
VOR / Vor Biopharma Inc.
|
|
6,477,999 |
6,457,293 |
|
|
|
2024-02-14 |
13G/A
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
3,425,988 |
|
|
|
2024-02-14 |
13G/A
|
NUVL / Nuvalent, Inc.
|
|
3,379,080 |
3,858,008 |
|
|
|
2024-02-05 |
13G
|
CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
399,658 |
|
|
|
2024-01-22 |
13G
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
1,927,506 |
|
|
|
2024-01-02 |
13G
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
3,425,988 |
|
|
|
2023-10-30 |
13G
|
NUVL / Nuvalent, Inc.
|
|
|
3,379,080 |
|
|
|
2023-09-25 |
13G
|
AMAM / Ambrx Biopharma Inc.
|
|
|
25,172,784 |
|
|
|
2023-09-25 |
13G
|
IRON / Disc Medicine, Inc.
|
|
|
1,235,918 |
|
|
|
2023-09-13 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
2,515,111 |
7,803,600 |
|
|
|
2023-07-21 |
13G
|
ACLX / Arcellx, Inc.
|
|
|
2,422,700 |
|
|
|
2023-07-10 |
13G
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
10,098,584 |
|
|
|
2023-05-11 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
1,891,167 |
2,310,698 |
|
|
|
2023-04-10 |
13G
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
2,515,111 |
|
|
|
2023-02-24 |
13G
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
1,610,665 |
|
|
|
2023-02-14 |
13G/A
|
OYST / Oyster Point Pharma Inc
|
|
1,462,576 |
0 |
|
|
|
2023-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
1,209,051 |
1,891,167 |
|
|
|
2023-02-14 |
13G/A
|
ALPN / Alpine Immune Sciences, Inc.
|
|
2,214,722 |
2,317,634 |
|
|
|
2023-02-14 |
13G/A
|
VOR / Vor Biopharma Inc.
|
|
2,328,494 |
6,477,999 |
|
|
|
2022-10-27 |
13G
|
VOR / Vor Biopharma Inc.
|
|
|
2,328,494 |
|
|
|
2022-10-03 |
13G
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
2,214,722 |
|
|
|
2022-07-18 |
13G
|
OYST / Oyster Point Pharma Inc
|
|
|
1,462,576 |
|
|
|
2022-02-14 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
1,209,051 |
|
|
|